Knight Initiative News

In which physician-scientist Marion Buckwalter shares the remarkable advances we've seen in stroke care in recent decades, thanks to long-standing national support for curiosity-driven research

In which anesthesiologist Martin Angst shares how studying the biology of recovery may reveal why some aging brains withstand stress while others quietly unravel.

In a favorite 2024 episode, we spoke with Jaimie Henderson, a Stanford neurosurgeon leading groundbreaking research in brain-machine interfaces.

In which Anthony Wagner and Beth Mormino share what they are learning from the Stanford Aging and Memory Study about the nature of healthy brain aging.

In which Wu Tsai Neuro faculty scholar Dan Yamins explores how foundation models of the human brain could revolutionize neuroscience.

In which Wu Tsai Neuro faculty scholar Laura Gwilliams explores how AI chatbots can model the human brain's language abilities.

This week on the podcast, Stanford cell biologist Brad Zuchero takes us on a tour of the frontiers of glia-science

This week on the podcast, Stanford radiology faculty Kim Butts Pauly and Raag Airan help us dive deep into the brain with focused ultrasound

This week on the podcast, Stanford psychiatry professor Erin Gibson joins us again to share the latest findings on sleep, myelin, and neurodegenerative disease.

This week on the podcast, Stanford neurobiologist Robert Sapolsky lays out his view that we should stop judging one another (and ourselves) for behaviors we can't control

We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression.

Today, we are going back into the archives for a conversation with neuroscientist, entrepreneur, and best-selling author David Eagleman about the science of synesthesia. If you don't know what that is, you're about to find out.

This week, we talk with our founding director, Bill Newsome, about the 10-year legacy of the NIH BRAIN Initiative and the uncertainty for the future brought on by this year's dramatic funding cuts.

This week we are talking with Stanford neuroscientist Ivan Soltesz about endocannabinoids, illuminating the "day job" of these unusual neurotransmitters and how they may be hijacked by cannabinoid drugs such as THC and CBD.

This week we are talking with Stanford neurobiologist Lisa Giocomo, exploring the intersection of memory, navigation, and the boundaries we create between ourselves and the world around us.

This week on From Our Neurons to Yours, we talk with Stanford neurologist Mike Greicius about his critique of new amyloid-clearing Alzheimer's drugs, and his optimism for the next wave of therapies currently in development.

This week on From Our Neurons to Yours, we talk with Leanne Williams about distinctive biotypes of depression revealed by brain imaging and AI, and the implications for therapy and mental health.

This week on From Our Neurons to Yours, we talk with Michelle Monje about her discovery that many cancers depend on nervous system innervation; she also discusses opportunities for novel therapies.

This week on From Our Neurons to Yours, we talk with Sergiu Pasca about using new techniques for growing human brain tissue in the lab to solve a rare neurological disorder.

This week, we talk with "radical behaviorist" Kim Bullock about how virtual reality technologies could serve as behavioral therapeutics to enhance psychotherapy.